Published in Eur J Hum Genet on March 01, 2001
The vexed question of authorship: views of researchers in a British medical faculty. BMJ (1997) 10.22
Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation (1995) 8.62
Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell (1997) 7.47
The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N Engl J Med (1995) 6.73
Guidelines for human gene nomenclature (1997). HUGO Nomenclature Committee. Genomics (1997) 6.44
Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science (1997) 6.10
Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell (1996) 5.99
Report of the DNA committee and catalogs of cloned and mapped genes and DNA polymorphisms. Cytogenet Cell Genet (1989) 5.48
Isolation and regional localization of DNA segments revealing polymorphic loci from human chromosome 13. Am J Hum Genet (1984) 3.86
Mutations in MVK, encoding mevalonate kinase, cause hyperimmunoglobulinaemia D and periodic fever syndrome. Nat Genet (1999) 3.35
Comparison of phenotypes of polycystic kidney disease types 1 and 2. European PKD1-PKD2 Study Group. Lancet (1999) 3.32
Ribosomal proteins of Escherichia coli. II. Proteins from the 30 s subunit. J Mol Biol (1968) 3.08
Screening elderly people in primary care: a randomized controlled trial. Br J Gen Pract (1990) 3.08
Mutations in ABCC6 cause pseudoxanthoma elasticum. Nat Genet (2000) 2.89
Maternal use of antiepileptic drugs and the risk of major congenital malformations: a joint European prospective study of human teratogenesis associated with maternal epilepsy. Epilepsia (1997) 2.82
MSH2 genomic deletions are a frequent cause of HNPCC. Nat Genet (1998) 2.73
[Risk factors for structural chromosomal abnormality in > or = 2 miscarriages, as an instrument for selective karyotyping]. Ned Tijdschr Geneeskd (2007) 2.71
The primary health care non-team. BMJ (1994) 2.66
Smith-Lemli-Opitz syndrome is caused by mutations in the 7-dehydrocholesterol reductase gene. Am J Hum Genet (1998) 2.62
Array-CGH detection of micro rearrangements in mentally retarded individuals: clinical significance of imbalances present both in affected children and normal parents. J Med Genet (2005) 2.60
The use of linked DNA polymorphisms for genotype prediction in families with Duchenne muscular dystrophy. J Med Genet (1983) 2.45
Familial endometrial cancer in female carriers of MSH6 germline mutations. Nat Genet (1999) 2.32
Report of the DNA committee and catalogues of cloned and mapped genes and DNA polymorphisms. Cytogenet Cell Genet (1990) 2.21
Colposcopic diagnosis and treatment of cervical dysplasia at a single clinic visit. Experience of low-voltage diathermy loop in 1000 patients. Lancet (1990) 2.06
In-utero exposure to valproate and neural tube defects. Lancet (1986) 1.98
Ribosomal proteins of E. Coli: stoichiometry and implications for ribosome structure. Cold Spring Harb Symp Quant Biol (1969) 1.83
Genotype-phenotype relationship in hereditary haemorrhagic telangiectasia. J Med Genet (2005) 1.76
Antiepileptic drug regimens and major congenital abnormalities in the offspring. Ann Neurol (1999) 1.73
The evolution of renal angiomyolipomas in patients with tuberous sclerosis. J Urol (1994) 1.73
Mutational spectrum of the TSC1 gene in a cohort of 225 tuberous sclerosis complex patients: no evidence for genotype-phenotype correlation. J Med Genet (1999) 1.71
Prognostic factors after a first attack of inflammatory CNS demyelination in children. Neurology (2008) 1.70
A novel protein tyrosine phosphatase gene is mutated in progressive myoclonus epilepsy of the Lafora type (EPM2). Hum Mol Genet (1999) 1.68
Gestation-induced changes in lamotrigine pharmacokinetics: a monotherapy study. Neurology (2004) 1.66
Genome search for susceptibility loci of common idiopathic generalised epilepsies. Hum Mol Genet (2000) 1.61
Genomic imbalances associated with mullerian aplasia. J Med Genet (2007) 1.61
The gene for triphalangeal thumb maps to the subtelomeric region of chromosome 7q. Nat Genet (1994) 1.56
Atypical HNPCC owing to MSH6 germline mutations: analysis of a large Dutch pedigree. J Med Genet (2001) 1.51
Ring chromosome 20 epilepsy syndrome in children: electroclinical features. Neurology (2001) 1.50
Prenatal diagnosis of spina bifida aperta after first-trimester valproate exposure. Prenat Diagn (1992) 1.50
Clinical approach to inherited peroxisomal disorders: a series of 27 patients. Ann Neurol (1998) 1.49
Peutz-Jeghers syndrome: 78-year follow-up of the original family. Lancet (1999) 1.46
FBXO7 mutations cause autosomal recessive, early-onset parkinsonian-pyramidal syndrome. Neurology (2008) 1.45
Majority of hMLH1 mutations responsible for hereditary nonpolyposis colorectal cancer cluster at the exonic region 15-16. Am J Hum Genet (1996) 1.43
The role of ultrasound in the early diagnosis of fetal structural defects following maternal anticonvulsant therapy. Ultrasound Med Biol (1988) 1.42
Repetitive electrical remodeling by paroxysms of atrial fibrillation in the goat: no cumulative effect on inducibility or stability of atrial fibrillation. J Cardiovasc Electrophysiol (1999) 1.42
[Lactic acidosis and accumulation of glutamate in the blood of neonates following treatment with calcium levulinate for hypocalcaemia]. Ned Tijdschr Geneeskd (2007) 1.40
Real-time three-dimensional myocardial contrast echocardiography: is it clinically feasible? Eur J Echocardiogr (2008) 1.40
Coexistence of Gaucher disease type 1 and Joubert syndrome. J Med Genet (1998) 1.40
Maternal 3-methylglutaconic aciduria associated with abnormalities in offspring. Lancet (1996) 1.40
Spinocerebellar ataxias in the Netherlands: prevalence and age at onset variance analysis. Neurology (2002) 1.40
Novel mutations in the LKB1/STK11 gene in Dutch Peutz-Jeghers families. Hum Mutat (1999) 1.39
High rate of mosaicism in tuberous sclerosis complex. Am J Hum Genet (1999) 1.38
Electrical remodeling due to atrial fibrillation in chronically instrumented conscious goats: roles of neurohumoral changes, ischemia, atrial stretch, and high rate of electrical activation. Circulation (1997) 1.37
Whole-genome array-CGH screening in undiagnosed syndromic patients: old syndromes revisited and new alterations. Cytogenet Genome Res (2006) 1.34
A novel disorder of N-glycosylation due to phosphomannose isomerase deficiency. Biochem Biophys Res Commun (1998) 1.27
Frequent deletion of the CDKN2A locus in chordoma: analysis of chromosomal imbalances using array comparative genomic hybridisation. Br J Cancer (2007) 1.27
A homozygous deletion of a normal variation locus in a patient with hearing loss from non-consanguineous parents. J Med Genet (2009) 1.26
Somatic mosaicism and clinical variation in tuberous sclerosis complex. Lancet (1995) 1.25
Early supported hospital discharge following acute stroke: pilot study results. Clin Rehabil (1997) 1.25
Pseudoxanthoma elasticum maps to an 820-kb region of the p13.1 region of chromosome 16. Genomics (1999) 1.24
Localization of genes on human chromosomes by studies of human-Chinese hamster somatic cell hybrids. Assignment of PGM3 to chromosome C6 and regional mapping of the PGD, PGM1 and pep-C genes on chromosome A1. Humangenetik (1973) 1.24
The use of new staining techniques for human chromosome identification. J Med Genet (1972) 1.23
Malignant pancreatic tumour within the spectrum of tuberous sclerosis complex in childhood. Eur J Pediatr (1999) 1.21
Contribution of CYLN2 and GTF2IRD1 to neurological and cognitive symptoms in Williams Syndrome. Neurobiol Dis (2006) 1.21
Osteosarcoma in preadolescent patients. Clin Orthop Relat Res (2000) 1.20
New problems in testing for Huntington's disease: the issue of intermediate and reduced penetrance alleles. J Med Genet (2001) 1.19
A case of ALS-FTD in a large FALS pedigree with a K17I ANG mutation. Neurology (2009) 1.19
Screening for asymptomatic bowel cancer in general practice. Br Med J (Clin Res Ed) (1984) 1.18
Genetic heterogeneity in tuberous sclerosis. Genomics (1990) 1.18
Prenatal exclusion of ornithine transcarbamylase deficiency by direct gene analysis. Lancet (1985) 1.16
Teratogenicity of antiepileptic drug combinations with special emphasis on epoxidation (of carbamazepine). Epilepsia (1984) 1.16
Autosomal dominant polycystic kidney disease: evidence for the existence of a third locus in a Portuguese family. Hum Genet (1995) 1.15
Defining the genetic contribution of type 2 diabetes mellitus. J Med Genet (2001) 1.14
Managing patient demand: a qualitative study of appointment making in general practice. Br J Gen Pract (2001) 1.14
The unfolding clinical spectrum of POLG mutations. J Med Genet (2009) 1.14
Single nucleotide polymorphism array analysis of chromosomal instability patterns discriminates rectal adenomas from carcinomas. J Pathol (2007) 1.13
Isolated polycystic liver disease as a distinct genetic disease, unlinked to polycystic kidney disease 1 and polycystic kidney disease 2. Hepatology (1996) 1.12
Hereditary hemorrhagic telangiectasia: ENG and ALK-1 mutations in Dutch patients. Hum Genet (2004) 1.11
Genomic alterations and gene expression in primary diffuse large B-cell lymphomas of immune-privileged sites: the importance of apoptosis and immunomodulatory pathways. J Pathol (2008) 1.11
Hypomyelination and reversible white matter attenuation in 3-phosphoglycerate dehydrogenase deficiency. Neuropediatrics (2000) 1.10
Congenital disorder of glycosylation type Ia: a clinicopathological report of a newborn infant with cerebellar pathology. Acta Neuropathol (2005) 1.10
Molecular and clinical characterization of a Moroccan Cog7 deficient patient. Mol Genet Metab (2007) 1.09
Organization of the mevalonate kinase (MVK) gene and identification of novel mutations causing mevalonic aciduria and hyperimmunoglobulinaemia D and periodic fever syndrome. Eur J Hum Genet (2001) 1.08
Isolated and contiguous glycerol kinase gene disorders: a review. J Inherit Metab Dis (2000) 1.08
Mapping DNA sequences in a human X-chromosome deletion which extends across the region of the Duchenne muscular dystrophy mutation. Am J Hum Genet (1985) 1.07
Familial multiple epiphyseal dysplasia due to a matrilin-3 mutation: further delineation of the phenotype including 40 years follow-up. Am J Med Genet A (2003) 1.06
Dynamic changes of plasma acylcarnitine levels induced by fasting and sunflower oil challenge test in children. Pediatr Res (1999) 1.05
Recurrent integration of human papillomaviruses 16, 45, and 67 near translocation breakpoints in new cervical cancer cell lines. Cancer Res (1999) 1.05
MRI of the brain and cervical spinal cord in rhizomelic chondrodysplasia punctata. Neurology (2006) 1.04
A novel CBFA2 single-nucleotide mutation in familial platelet disorder with propensity to develop myeloid malignancies. Blood (2001) 1.04
1q gain and CDT2 overexpression underlie an aggressive and highly proliferative form of Ewing sarcoma. Oncogene (2011) 1.02
Haemoccult compliance rates and reasons for non-compliance. Public Health (1984) 1.02
A comparative study on genetic heterogeneity in tuberous sclerosis: evidence for one gene on 9q34 and a second gene on 11q22-23. Ann N Y Acad Sci (1991) 1.01
Complementation analysis of patients with intact peroxisomes and impaired peroxisomal beta-oxidation. Biochem Med Metab Biol (1993) 1.01
Norrie's disease: close linkage with genetic markers from the proximal short arm of the X chromosome. Clin Genet (1985) 1.00
Infantile Refsum's disease: biochemical findings suggesting multiple peroxisomal dysfunction. J Inherit Metab Dis (1986) 0.99
Large deletion of the peroxisomal acyl-CoA oxidase gene in pseudoneonatal adrenoleukodystrophy. J Clin Invest (1994) 0.99